Title: Pharmaceutical science to improve the human condition
Description: "This Annals volume presents the scientific achievements by winners and finalists of the 2012 Prix Galien USA. Contributions include scholarly summaries from biopharmaceutical industry leaders (GlaxoSmithKline, MethylGene, Bristol-Myers Squibb, Novartis, Optimer Pharmaceuticals, Janssen, Bayer, Merck, UCB Pharma, Medtronic, and Novocure) on pharmaceutical advances in the treatment of a wide range of diseases including advanced melanoma, C. difficile-associated diarrhea, partial-onset seizures, chronic hepatitis C infection, recurrent glioblastoma, and thrombosis-mediated conditions, as well as advances in transcatheter valve technology and ventricular assist devices"--
Subjects: Pharmaceutical industry, Awards and Prizes, Pharmacology, Drug Industry, Drug Discovery, Pharmaceutical Technology